Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
SurgiWipe, LLC currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, TIEN, LUCY MINYU, who is also the busiest examiner with 1 pending office action. The portfolio is active in 1 distinct art unit.
The presence of 1 pending office action indicates a focused prosecution stage. Because TIEN, LUCY MINYU is the only examiner involved, the applicant's current success at the USPTO is tied to this 1 individual. The 1 distinct art unit suggests that the technology being pursued is specialized within the biotech or pharmaceutical fields.
This concentration means the applicant does not have to manage multiple examiner styles or varying art unit standards across the 1 pending action. Practitioners should focus their resources on the specific requirements of the assigned art unit. The outcome of this single office action will define the immediate success rate for the portfolio, allowing the legal team to prioritize the preferences of TIEN, LUCY MINYU.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TIEN, LUCY MINYU | 1 | 59.3% | +39.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18382741 | TOPICAL ANTISEPTIC | TIEN, LUCY MINYU | 27d |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18382741 | TOPICAL ANTISEPTIC | TIEN, LUCY MINYU | 1612 | §103 | Final Rejection | 27d | Pending | Oct 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial